Delivering Orally Bioavailable Peptides with Increased Stability & Half-Life Through Formulation Innovation
Time: 11:30 am
day: Conference Day Two
Details:
- Collaborating with formulation teams to learn how to optimize formulation for peptides of different sizes • Discussing biopharmaceutics mechanisms for different oral formulation platforms
- Translating formulation considerations into early-stage design of peptides with clinical viability potential
- Sharing key learnings from the successful launch of oral semaglutide and continued success of subcutaneous peptide products
